Appili Therapeutics
Dr. Leona Saunders has a wealth of experience developing and implementing regulatory strategies for pharmaceutical, biotech, and medical device companies. With over two decades of experience, she has made significant contributions to the planning, execution, and submission of various regulatory applications.
Dr. Saunders' expertise extends to writing and editing clinical and nonclinical documentation and serving as the lead regulatory author on multiple programs for submissions to FDA and various international regulatory authorities. Dr. Saunders' academic qualifications include a Doctorate in Law and Public Policy, a Master's degree in Regulatory Affairs, and a Bachelor's degree in Leadership in Bioscience, all from Northeastern University. She also holds a Master's degree in Public Health from Florida International University. Her extensive educational background has given her a strong foundation in the legal, policy, and scientific aspects of regulatory affairs, enabling her to offer a comprehensive approach to regulatory strategy.
This person is not in any teams
This person is not in any offices
Appili Therapeutics
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. The Company is currently advancing a diverse range of anti-infectives, including a vaccine candidate to eliminate a serious biological weapon threat, a topical antiparasitic for the treatment of a disfiguring disease, and a novel easy to use, liquid oral formulation targeting parasitic and anaerobic infections.